BioRestorative Therapies (FRA:9OF) EV-to-Revenue : -14.77 (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is BioRestorative Therapies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioRestorative Therapies's enterprise value is €-1.99 Mil. BioRestorative Therapies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.14 Mil. Therefore, BioRestorative Therapies's EV-to-Revenue for today is -14.77.

The historical rank and industry rank for BioRestorative Therapies's EV-to-Revenue or its related term are showing as below:

FRA:9OF' s EV-to-Revenue Range Over the Past 10 Years
Min: -188.91 Med: 74.83 Max: 20263.32
Current: -14.77

During the past 13 years, the highest EV-to-Revenue of BioRestorative Therapies was 20263.32. The lowest was -188.91. And the median was 74.83.

FRA:9OF's EV-to-Revenue is ranked better than
97.4% of 1038 companies
in the Biotechnology industry
Industry Median: 8.145 vs FRA:9OF: -14.77

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), BioRestorative Therapies's stock price is €1.12. BioRestorative Therapies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.03. Therefore, BioRestorative Therapies's PS Ratio for today is 33.94.

BioRestorative Therapies EV-to-Revenue Historical Data

The historical data trend for BioRestorative Therapies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRestorative Therapies EV-to-Revenue Chart

BioRestorative Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

62.62

278.91

-110.05

-35.99

-18.50

BioRestorative Therapies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-35.99	5.33	48.03	-28.03	-18.50

Competitive Comparison of BioRestorative Therapies's EV-to-Revenue

For the Biotechnology subindustry, BioRestorative Therapies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioRestorative Therapies's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's EV-to-Revenue falls into.

BioRestorative Therapies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioRestorative Therapies's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-1.994	/	0.135
	=	-14.77

BioRestorative Therapies's current Enterprise Value is €-1.99 Mil.
BioRestorative Therapies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.14 Mil.

BioRestorative Therapies (FRA:9OF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioRestorative Therapies's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.12	/	0.033
	=	33.94

BioRestorative Therapies's share price for today is €1.12.
BioRestorative Therapies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03.

BioRestorative Therapies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioRestorative Therapies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRestorative Therapies (FRA:9OF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioRestorative Therapies Inc (FRA:9OF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BRTX:USA

Address

40 Marcus Drive, Suite One, Melville, NY, USA, 11747

Website

https://www.biorestorative.com

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

BioRestorative Therapies (FRA:9OF) Headlines

No Headlines